{"database":"biostudies-literature","file_versions":[],"scores":null,"additional":{"omics_type":["Unknown"],"volume":["14(1)"],"submitter":["Braik R"],"pubmed_abstract":["<h4>Background</h4>The transfusion strategy in the acute phase of myocardial infarction (AMI) remains a debated topic with non-standardized guidelines. This study aimed to evaluate the impact of liberal versus restrictive transfusion strategies on mortality during AMI.<h4>Methods</h4>A systematic search was conducted across MEDLINE, EMBASE, and the COCHRANE library databases, focusing on randomized controlled trials (RCTs). The primary endpoint was the latest measured mortality within 90 days following myocardial infarction (MI). Secondary endpoints included recurrence of MI, cardiovascular mortality, stroke occurrence, unplanned revascularization, and a composite endpoint of death or recurrent MI. Mixed and random-effects models were employed to estimate relative risks. Sensitivity analys"],"journal":["Annals of intensive care"],"pagination":["150"],"full_dataset_link":["https://www.ebi.ac.uk/biostudies/studies/S-EPMC11438751"],"repository":["biostudies-literature"],"pubmed_title":["Liberal versus restrictive transfusion strategies in acute myocardial infarction: a systematic review and comparative frequentist and Bayesian meta-analysis of randomized controlled trials."],"pmcid":["PMC11438751"],"pubmed_authors":["Blot PL","James A","Constantin JM","Jebali S","Egbeola J","Braik R"],"additional_accession":[]},"is_claimable":false,"name":"Liberal versus restrictive transfusion strategies in acute myocardial infarction: a systematic review and comparative frequentist and Bayesian meta-analysis of randomized controlled trials.","description":"<h4>Background</h4>The transfusion strategy in the acute phase of myocardial infarction (AMI) remains a debated topic with non-standardized guidelines. This study aimed to evaluate the impact of liberal versus restrictive transfusion strategies on mortality during AMI.<h4>Methods</h4>A systematic search was conducted across MEDLINE, EMBASE, and the COCHRANE library databases, focusing on randomized controlled trials (RCTs). The primary endpoint was the latest measured mortality within 90 days following myocardial infarction (MI). Secondary endpoints included recurrence of MI, cardiovascular mortality, stroke occurrence, unplanned revascularization, and a composite endpoint of death or recurrent MI. Mixed and random-effects models were employed to estimate relative risks. Sensitivity analys","dates":{"release":"2024-01-01T00:00:00Z","publication":"2024 Sep","modification":"2025-04-04T01:14:25.508Z","creation":"2025-04-04T01:14:25.508Z"},"accession":"S-EPMC11438751","cross_references":{"pubmed":["39340600"],"doi":["10.1186/s13613-024-01376-1"]}}